SCHEMBL6406053

SCHEMBL6406053

CCOCCSc1nnc(-c2ccccc2)[nH]1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
POLB P06746 2/20 0.39
SMN1; SMN2 Q16637 3/20 0.38
LMNA P02545 2/20 0.38
MAPT P10636 1/20 0.38
HPGD P15428 1/20 0.38
HTT P42858 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
XDH P47989 1/20 0.37
EGFR P00533 1/20 0.37
TUBB4A P04350 1/20 0.37
TUBB P07437 1/20 0.37
TUBA3C P0DPH7 1/20 0.37
TUBA1B P68363 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6408678 0.85 CYP3A4 (0.40) KMT2APOLBSMN1; SMN2LMNAMAPT
SCHEMBL6405546 0.80 HRH1 (0.42) MEN1KMT2APOLBSMN1; SMN2LMNA
SCHEMBL23527287 0.79 AR (0.57) MEN1KMT2APOLBSMN1; SMN2LMNA
SCHEMBL6405444 0.79 ALDH1A1 (0.39) MEN1KMT2AL3MBTL1POLBSMN1; SMN2
SCHEMBL6404441 0.77 ALPL (0.53) MEN1KMT2AL3MBTL1POLBSMN1; SMN2
SCHEMBL6942674 0.75 KDM4E (0.56) L3MBTL1LMNAHPGDKDM4EALDH1A1
SCHEMBL6406096 0.75 RAB9A (0.52) L3MBTL1POLBMAPTNPSR1CYP1A2
SCHEMBL9331958 0.71 L3MBTL1 (0.53) MEN1KMT2AL3MBTL1POLBLMNA
SCHEMBL14652837 0.70 ALDH1A1 (0.58) MEN1KMT2ASMN1; SMN2LMNAMAPT
SCHEMBL6404737 0.70 TNKS (0.46) POLBHPGDHTTCYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof AGRIUS GROUP, LLC. 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof ABCG2, ATP5ME, DNTT MEN1 3562/4885KMT2A 2263/4885L3MBTL1 2749/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.